Is intravenous golimumab effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2 : results of the phase 3 , randomised , multicentre , double-blind , placebo-controlled GO-FURTHER trial?
The addition of intravenous golimumab rapidly and significantly improved signs and symptoms in patients with active RA despite ongoing MTX, in some patients by week 2.
The determining compound for the observed anxiolytic effect of the valerian extract is its content of valerenic acid.